Coreline Soft’s Strategic Vision for Global Expansion: Insights from JFR 2024

Attending JFR 2024 was a truly transformative experience for me as part of Coreline Soft’s global team. Held in the heart of Paris, this prestigious congress brought together the brightest minds in radiology, creating the perfect environment to showcase our innovative solutions and connect with industry leaders.
As I walked through the bustling exhibition halls, I witnessed first-hand the excitement around advancements in AI and its potential to revolutionize healthcare. From sharing Coreline Soft’s vision with French radiology professionals to exploring new collaborations, the event reinforced our commitment to driving meaningful change in lung cancer screening and beyond.
The French Society of Radiology Congress (JFR) is more than just an industry event—it is a gateway to the heart of the European radiology market. As a key annual gathering for radiology experts, academics, and medical professionals, JFR provides a platform for innovation, collaboration, and strategic networking. In 2024, Coreline Soft leveraged its participation at JFR to strengthen its footprint in France and position itself for further growth in the global lung cancer screening market.


JFR 2024: A Catalyst for Innovation and Collaboration

---

Held in Paris from October 4 to 7, JFR 2024 focused on the latest advancements in radiology technology, with particular emphasis on AI and clinical applications. Coreline Soft has been a regular participant since 2023, showcasing its AVIEW platform and demonstrating its transformative capabilities in early lung cancer detection.
Coreline Soft’s engagement at JFR goes beyond product promotion. This event enables us to collaborate with France’s leading radiologists and decision-makers while fostering long-term relationships with Key Opinion Leaders (KOLs) and healthcare institutions. With 93% of attendees being from France and 62% representing radiology professionals, JFR offers unparalleled access to a focused and relevant audience.


Strategic Wins and Opportunities from JFR 2024

---

AVIEW’s Strong Reception: Coreline Soft presented AVIEW’s advanced solutions, including nodule detection and complementary functionalities, which garnered significant interest. Over 40 consultations were conducted during the event, with 16 converting into direct sales opportunities.

Strengthened Partnerships: Coreline Soft and Milvue participated jointly for the first time at JFR, highlighting the synergy between Coreline’s CT imaging solutions and Milvue’s X-ray AI expertise. This collaboration not only generated 13 new leads but also rekindled dormant relationships with key clients.

Additionally, discussions with Incepto laid the groundwork for expanding Coreline Soft’s presence in the French market in 2025.

Reflections and Recommendations for the Future

---

Localized Engagement: While English remains essential, incorporating French-language materials and staff at the booth would significantly enhance visitor experiences. This tailored approach can leave a lasting impression on French professionals and foster deeper connections.

Enhanced Presentation Strategies: Competitors at JFR effectively utilized clinical data and research outcomes to captivate audiences. Coreline Soft can amplify its presence by collaborating with renowned KOLs, such as KOL(Key Opinion Leader) to present impactful clinical results at future events.

New Functionalities to Meet Market Demands: Features like voice-recognition-based reporting tools, showcased by other companies, were highly regarded for their potential to reduce radiologists’ workloads. Integrating such functionalities into Coreline Soft’s solutions could further enhance market competitiveness.

A Vision for Global Growth

---

Coreline Soft is proud to lead the way in healthcare innovation with our advanced AI-powered medical imaging technology. Recently, our AVIEW LCS was recognized in Scientific Reports for its outstanding performance in early lung cancer detection, surpassing Siemens’ ‘ChestCTExplore.’ This recognition highlights the strength of our technology and reinforces our position as a global leader.

We’ve already seen success in Europe, including key markets like Germany, Italy, and Norway, and we’re now focusing on accelerating adoption in the French public hospital market. Our aim is to expand beyond Paris and bring our solutions to hospitals nationwide, strengthening our impact across France.

At the same time, we’re working to grow in other markets like Belgium, Portugal, Finland, and Lithuania, as well as globally in regions such as Australia and the Middle East, where lung cancer screening projects are creating exciting opportunities for collaboration.

At Coreline Soft, we are dedicated to supporting healthcare professionals and improving patient care through innovative, tailored solutions. By setting a new global standard for AI-powered medical imaging, we aim to transform radiology and redefine what’s possible in healthcare.